• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. CCL21 facilitates chemoresistance and cancer stem cell-like properties of colorectal cancer cells th

CCL21 facilitates chemoresistance and cancer stem cell-like properties of colorectal cancer cells th

来源 :2016医学科学前沿暨第四届个体化治疗与抗肿瘤药物研究新趋向研讨会 | 被引量 : 0次 | 上传用户：gf_lucky
【摘 要】
：
Tumor drug resistance is the main reason for the failure of tumor chemotherapy,but the underlying mechanisms are various,which is a big problem in the clinical treatment.A large number of studies have
【作 者】
：
Lin-Lin Lu Xiao-Hui Chen Ge Zhang Zong-Cai Liu Nong Wu Hao Wang Yi-Fei Qi Hong-Sheng Wang Shao-Hui Cai Jun Du 
【机 构】
：
Department of Microbial and Biochemical Pharmacy,School of Pharmaceutical Sciences,Sun Yat-sen Unive
【出 处】
：
2016医学科学前沿暨第四届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
：
2016年10期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Tumor drug resistance is the main reason for the failure of tumor chemotherapy,but the underlying mechanisms are various,which is a big problem in the clinical treatment.A large number of studies have shown that drug resistance is related with stem cell properties,and cytokines in tumor microenvironment are associated with the development of tumor chemoresistance and stem cell property.
其他文献
PTPRO represses ERBB2-positive breast cancer via dephosphorylation and endosomal internalization of
Aim: Recent research from our lab has presented evidence that the DNA methylation status of PTPRO is a prognostic factor in ERBB2-positive breast cancer.However,the inherent role of PTPRO in oncogenes
会议
PTPROERBB2-positive breast cancerDephosphorylationAKT/ERK signaling
老药新用,二甲双胍的抗肿瘤作用研究
目的：小分子化学药物对于肿瘤靶向治疗和个体化治疗具有重要意义。但开发小分子抗肿瘤新药需要消耗大量时间、精力和成本。较之开发新药，挖掘传统非肿瘤药物的抗肿瘤功效是一个捷径，二甲双胍是老药新用的一个典范。
会议
二甲双胍肿瘤防治食管鳞癌综述
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregul
Aim: Growth hormone-releasing hormone(GHRH)and GHRH receptor(GHRH-R)have been found to be present in a variety of tumoral tissues and cell lines.The aim of this study is to demonstrate that GHRH-R ant
会议
GHRHGastric cancerPAK1NF-κBStat3
Benefit of metformin in human esophageal carcinoma:preclinical studies and clinical trials
Aim: The anti-diabetic drug metformin exerts chemopreventive and antineoplastic effects in many types of malignancies.We previously described the in vitro and in vivo effects of metformin on esophagea
会议
Esophageal squamous cell carcinomaMetforminproliferationclinical trials
耐药相关核蛋白PSF细胞膜表达水平与髓系白血病预后的关系
会议
MTA3-mediated regulation of cancer hallmarks:epithelial-mesenchymal transition and beyond
Aim: Currently,there are no specific therapies that effectively impede metastasis.Metastatic processes are controlled by the complex regulatory networks and the transcriptional hierarchy.Corepressor M
会议
Metastasis associated proteinsCoregulatorNuRD complexMaster regulator
Effects of Cytochrome P450 3A4 and non-genetic factors on initial Voriconazole serum trough concentr
会议
Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells
Rottlerin,isolated from a medicinal plant Mallotus phillippinensis,has been demonstrated to inhibit cellular growth and induce cytoxicity in glioblastoma cell lines through inhibition of calmodulin-de
会议
Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic ca
Pancreatic cancer(PC)is one of the most aggressive human malignancies worldwide and is the fourth leading cause of cancer-related deaths.Curcumin(diferuloylmethane)is a polyphenol derived from the Cur
会议
靶向抑制PD-L1的苦豆碱类衍生物肿瘤免疫治疗及其作用机制研究
2011 年开始,恶性肿瘤已经超过心脏病,已经成为全球第一大死亡原因.进入21世纪以来一直以来,以免疫学为基础建立起的肿瘤免疫疗法已成为继手术、化疗、放疗和靶向治疗后的一种新的有效疗法.针对免疫检查点的阻断是众多激活抗肿瘤免疫的有效策略之一.PD-L1,作为T 细胞表面PD-1 的配体高表达于多种恶性肿瘤细胞的表面,其与PD-1相互作用后可以抑制T 细胞的增殖,细胞因子的释放从而抑制机体对于肿瘤细
会议